Characteristics of metabolically obese normal-weight (MONW) subjects

Applied Physiology, Nutrition and Metabolism

Volumn 32, Issue 1, 2007, Pages 4-12

  Conus, Florence ^a   Rabasa Lhoret, Rémi ^a   Péronnet, François ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adipose tissue distribution; Dyslipidemia; Insulin sensitivity; Metabolic syndrome; MONW; Physical activity

Indexed keywords

ARTICLE; BODY MASS; BODY WEIGHT; FEMALE; HUMAN; MALE; METABOLISM; OBESITY; RISK FACTOR;

BODY MASS INDEX; BODY WEIGHT; FEMALE; HUMANS; MALE; OBESITY; RISK FACTORS;

EID: 34047192518     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H06-092     Document Type: Article

References (45)

1. Conus, F., Allison, D.B., Rabasa-Lhoret, R., St-Onge, M., St-Pierre, D.H., Tremblay-Lebeau, A., et al. 2004. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J. Clin. Endocrinol. Metab. 89: 5013-5020. doi:10. 1210/jc.2004-0265. PMID:15472199.
2. Diamond, M.P., Thornton, K., Connolly-Diamond, M., Sherwin, R.S., and DeFonzo, R.A. 1995. Reciprocal variations in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance. J. Soc. Gynecol. Investig. 2: 708-715. PMID:9420879.
3. Dvorak, R.V., DeNino, W.F., Ades, P.A., and Poehlman, E.T. 1999. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes, 48: 2210-2214. PMID: 10535456.
4. Fagerberg, B., Bondjers, L., and Nilsson, P. 2004. Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study. J. Intern. Med. 256: 254-259. doi10.1111/j.1365-2796.2004.01361.x. PMID:15324369.
5. Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., and Mingrone, G. 1997. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J. Clin. Invest. 100: 1166-1173. PMID:9303923.
6. Freedland, E.S. 2004. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implication for controlling dietary carbohydrates: a review. Nutr. Metab. 1: 1-24.
7. Gill, J.M., and Malkova, D. 2006. Physical activity, fitness and cardiovascular disease risk in adults: interactions with insulin resistance and obesity. Clin. Sci. (Lond.), 110: 409-425. PMID:16526946.
8. Goodpaster, B.H., Krishnaswami, S., Resnick, H., Kelley, D.E., Haggerty, C., Harris, T.B., et al. 2003. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care, 26: 372-379. PMID: 12547865.
9. Haffner, S.M., Mykkänen, L., Festa, A., Burke, J.P., and Stern.M.P. 2000. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects. Circulation, 101: 975-980. PMID: 10704163.
10. Hayashi, T., Boyko, E.J., Leonetti, D.L., McNeely, M.J., Newell-Morris, L., Kahn, S.E., et al. 2004. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann. Intern. Med. 140: 992-1000. PMID:15197016.
11. Hollenbeck, C., and Reaven, G.M. 1987. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J. Clin. Endocrinol. Metab. 64: 1169-1173. PMID:3553221.
12. Homma, Y. 2004. Predictors of atherosclerosis. J. Atheroscler. Thromb. 11: 265-270. PMID:15557708.
13. Kahn, R., Buse, J., Ferrannini, E., and Stern, M. 2005. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 28: 2289-2304. PMID:16123508.
14. Karelis, A.D., St-Pierre, D.H., Conus, F., Rabasa-Lhoret, R., and Poehlman, E.T. 2004. Metabolic and body composition factors in subgroups of obesity: What do we know? J. Clin. Endocrinol. Metab. 89: 2569-2575. doi:10.1210/jc.2004-0165. PMID:15181025.
15. Katsuki, A., Sumida, Y., Urakawa, H., Gabazza, E.C., Murashima, S., Maruyama, N., et al. 20030. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care, 26: 2341-2344. PMID:12882859.
16. Katsuki, A., Sumida, Y., Urakawa, H., Gabazza, E.C., Murashima, S., Matsumoto, K., et al. 2003b. Plasma levels of adiponectin are associated with insulin resistance and serum levels of triglyceride in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care, 26: 2964-2965. PMID:14514619.
17. Katsuki, A., Sumida, Y., Urakawa, H., Gabazza, E.C., Murashima, S., Nakatani, K., et al. 2004. Increased oxidative stress is associated with serum levels of triglyceride, insulin resistance, and hyperinsulinemia in Japanese metabolically obese, normal-weight men. Diabetes Care, 27: 631-632. PMID: 14747267.
18. Katsuki, A., Urakawa, H., Gabazza, E.C., Murashima, S., Nakatani, K., Togashi, K., et al. 2005. Quantitative insulin sensitivity check index is a useful indicator of insulin resistance in Japanese metabolically obese, normal-weight subjects with normal glucose tolerance. Endocr. J. 52: 253-257. doi:10.1507/endocrj.52.253. PMID:15863957.
19. Katzmarzyk, P.T., Church, T.S., and Blair, S.N. 2004. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch. Intern. Med. 164: 1092-1097. doi:10.1001/archinte.164.10.1092. PMID:15159266.
20. Kelley, D.E., Thaete, F.L., Troost, F., Huwe, T., and Goodpaster, B.H. 2000. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 278: E941-E948. PMID: 10780952.
21. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., et al. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346: 393-403. PMID:11832527.
22. Landin, K., Krotkiewski, M., and Smith, U. 1989. Importance of obesity for the metabolic abnormalities associated with an abdominal fat distribution. Metabolism, 38: 572-576. doi:10.1016/0026-0495(89)90219-9. PMID:2657328.
23. Landin, K., Lonnroth, P., Krotkiewski, M., Holm, G., and Smith, U. 1990. Increased insulin resistance and fat cell lipolysis in obese but not lean women with a high waist/hip ratio. Eur. J. Clin. Invest. 20: 530-535. PMID:2124985.
24. Malloy, M.J., and Kane, J.P. 2001. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv. Intern. Med. 47: 111-136. PMID:11795072.
25. Meigs, J.B., Wilson, P.W., Fox, C.S., Vasan, R.S., Nathan, D.M., Sullivan, L.M., et al. 2006. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J. Clin. Endocrinol. Metab. 91: 2906-2912. doi:10.1210/jc.2006-0594. PMID:16735483.
26. Molero-Conejo, E., Morales, L.M., Fernandez, V., Raleigh, X., Gomez, M.E., Semprun-Fereira, M., et al. 2003. Lean adolescents with increased risk for metabolic syndrome. Arch. Latinoam. Nutr. 53: 39-46. PMID: 12942870.
27. Monzillo, L.U., and Hamdy, O. 2003. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr. Rev. 61: 397-412. doi:10.1301/nr.2003.dec.397-412. PMID:14968910.
28. Panel on Dietary Reference Intakes for Macronutrients Food and Nutrition Board. 2002. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (macronutrients). The National Academies Press, Institute of Medicine, Washington, D.C.
29. Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M.R., and Heymsfield, S.B. 2003. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch. Intern. Med. 163: 427-436. doi:10.1001/archinte.163.4.427. PMID:12588201.
30. Phillips, D.I. 2004. Fetal programming of the neuroendocrine response to stress: links between low birth weight and the metabolic syndrome. Endocr. Res. 30: 819-826. doi:10.1081/ERC-200044086. PMID:15666832.
31. Reynolds, K., and He, J. 2005. Epidemiology of the metabolic syndrome. Am. J. Med. Sci. 330: 273-279. doi:10.1097/00000441-200512000-00004. PMID:16355011.
32. Richelsen, B., and Pedersen, S.B. 1995. Associations between different anthropometric measurements of fatness and metabolic risk parameters in non-obese, healthy, middle-aged men. Int. J. Obes. Relat. Metab. Disord. 19: 169-174. PMID:7780492.
33. Ruderman, N.B., Schneider, S.H., and Berchtold, P. 1981. The "metabolically-obese", normal-weight individual. Am. J. Clin. Nutr. 34: 1617-1621. PMID:7270486.
34. Ruderman, N.B., Berchtold, P., and Schneider, S.H. 1982. Obesity-associated disorders in normal-weight individuals: some speculations. Int. J. Obes. 6: suppl. 1, 151-157. PMID:6749721.
35. Ruderman, N., Chrisholm, D., Pi-Sunyer, X., and Schneider, S.H. 1998. The metabolically obese, normal-weight individual revisited. Diabetes, 47: 699-713. PMID:9588440.
36. Shinozaki, K., Kashiwagi, A., Masada, M., and Okamura, T. 2004. Molecular mechanisms of impaired endothelial function associated with insulin resistance. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4: 1-11. doi:10.2174/1568006043481248. PMID:15032648.
37. Sims, E.A. 2001. Are there persons who are obese, but metabolically healthy? Metabolism, 50: 1499-1504. doi:10.1053/meta.2001.27213. PMID:11735101.
38. St-Onge, M.-P., Janssen, I., and Heymsfield, S.B. 2004. Metabolic syndrome in normal-weight Americans. New defintion of the metabolically obese, normal-weight individual. Diabetes Care, 27: 2222-2228. PMID:15333488.
39. Steinberg, H.O., and Baron, A.D. 2002. Vascular function, insulin resistance and fatty acids. Diabetologia, 45: 623-634. PMID:12107742.
40. Stout, R.W. 1996. Hyperinsulinemia and atherosclerosis. Diabetes, 45: Suppl 3, S45-S46. PMID:8674889.
41. Taylor, H.L., Jacobs, D.R., Jr., Schucker, B., Knudsen, J., Leon, A.S., and Debacker, G. 1978. A questionnaire for the assessment of leisure time physical activities. J. Chronic Dis. 31: 741-755. doi:10.1016/0021- 9681(78)90058-9. PMID:748370.
42. National Cholesterol Education Program Expert Panel on Detection. 2002. Third Report of the National Cholesterol Education Program Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Final report, National Institutes of Health, National Heart, Lung, and Blood Institute, No. NIH 02-5215.
43. Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., et al. 2001. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344: 1343-1350. doi:10.1056/NEJM200105033441801. PMID:11333990.
44. Yang, B., Li, T.D., Wang, J.S., Zhi, G., Jin, W.S., and Xu, Y. 2005. Insulin resistance and carotid atherosclerosis in 221 patients with potential hyperglycemia. Chin. Med. Sci. J. 20: 108-111. PMID:16075748.
45. Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., et al. 1989. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N. Engl. J. Med. 320: 702-706. PMID:2646537.